CorMedix Inc.
(NYSE Amex Equities : CRMD)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Are you a Dividend Trader
Learn how to make passive income from the best dividend stocks.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Medical Specialties
symbolcompany%chnglast%shortavg$volume
ABTAbbott Laboratories
1.74%75.260.8%$473.31m
MDTMedtronic PLC
1.16%92.290.6%$467.57m
ISRGIntuitive Surgical, Inc.
2.32%548.502.4%$425.24m
TMOThermo Fisher Scientific Inc.
2.56%252.441.0%$395.89m
ALGNAlign Technology, Inc.
1.68%254.966.3%$378.26m
SYKStryker Corporation
0.67%186.791.3%$314.48m
BSXBoston Scientific Corporation
0.23%40.011.1%$294.43m
BDXBecton, Dickinson and Company
1.59%248.391.1%$270.36m
TFXTeleflex Incorporated
1.51%285.785.4%$247.14m
BAXBaxter International Inc.
1.38%73.441.7%$223.09m
EWEdwards Lifesciences Corporation
0.95%177.791.2%$215.36m
ABMDABIOMED, Inc.
1.19%362.063.3%$187.02m
WATWaters Corporation
1.39%234.713.5%$175.89m
ZBHZimmer Biomet Holdings, Inc.
0.94%123.641.7%$173.58m
DXCMDexCom, Inc.
0.45%148.498.5%$159.41m

Company Profile

CorMedix, Inc. operates as a pharmaceutical and medical device company that seeks to in-license, develop and commercialize prophylactic and therapeutic products for the prevention and treatment of infectious and inflammatory diseases. The firm is developing its product Neutrolin, a novel, non-antibiotic antimicrobial solution designed to prevent costly and dangerous bloodstream infections associated with the use of central venous catheters. The company was founded by Antony E. Pfaffle on July 28, 2006 and is headquartered in Berkeley Heights, NJ.